DPP4 and Insulin resistance: In this cross-sectional study fasting serum dipeptidyl peptidase 4 activity and insulin resistance were assessed in two selected groups of patients, one with non-alcoholic fatty liver disease and the other with type 2 diabetes mellitus without clinically evident liver disease and all results were compared to that of healthy controls (table 1).